Form 8-K - Current report:
SEC Accession No. 0001104659-20-117141
Filing Date
2020-10-22
Accepted
2020-10-22 16:05:36
Documents
1
Period of Report
2020-10-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2033891d1_8k.htm 8-K 20193
  Complete submission text file 0001104659-20-117141.txt   21543
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 201254993
SIC: 2834 Pharmaceutical Preparations